V019-2841 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine

V019-2841 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine
V019-2841 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-2841
1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-2841

Molecular Formula

C35H38N4O3S (C35 H38 N4 O3 S)

Compound Name

1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine

IUPAC name

1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[12-a]pyridin-3-yl]methyl}-4-(3-methoxycyclohexanecarbonyl)piperazine

SMILES

COC(CCC1)CC1C(N1CCN(Cc2c(-c(cc3)ccc3OC)nc(cc3)n2cc3-c2cc(cccc3)c3s2)CC1)=O

InChI

InChI=1S/C35H38N4O3S/c1-41-28-13-10-24(11-14-28)34-30(23-37-16-18-38(19-17-37)35(40)26-7-5-8-29(20-26)42-2)39-22-27(12-15-33(39)36-34)32-21-25-6-3-4-9-31(25)43-32/h3-4,6,9-15,21-22,26,29H,5,7-8,16-20,23H2,1-2H3

InChI Key

LWSLEWRGQNFZPL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20495509

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

594.78

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.799

Distribution Coefficient, logD

5.797

Water Solubility, LogSw

-6.20

Polar Surface Area

43.956

Acid Dissociation Constant (pKa)

23.65

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

37.10

V019-2841 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with V019-2841 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-2841?
Check Price and Availability of V019-2841, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-2841 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-2841
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-2841
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-2841 available by request